language-icon Old Web
English
Sign In
Acemap > Paper > Considering FOLFOXIRI plus bevacizumab for metastatic colorectal cancer with left-sided tumors

Considering FOLFOXIRI plus bevacizumab for metastatic colorectal cancer with left-sided tumors

2018 
Considering FOLFOXIRI plus bevacizumab for metastatic colorectal cancer with left-sided tumors
Keywords:
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    9
    References
    1
    Citations
    NaN
    KQI
    []
    logo
    • CCF Conference Analysis
    • Map Galaxy
    • What's New
    © Copyright 2015-2020 Acemap, Inc. Shanghai Jiao Tong University.